Structure-activity relationships (SAR) of [D-Arg(2)]dermorphin(1-4) analogues, N(alpha)-amidino-Tyr-D-Arg-Phe-X. 2002

Tadashi Ogawa, and Tetsuhisa Miyamae, and Toru Okayama, and Masaki Hagiwara, and Shinobu Sakurada, and Tadanori Morikawa
Research Institute, Daiichi Fine Chemical Co., Ltd., Takaoka, Toyama, Japan.

In investigating the development of compounds with potent analgesic effects after oral administration, 74 C-terminal analogues (N(alpha)-amidino-Tyr-D-Arg-Phe-X), based on the structure of N(alpha)-amidino-Tyr-D-Arg-Phe-Me beta Ala-OH (ADAMB), were synthesized. Their analgesic activity was evaluated using the mouse-tail pressure test after both subcutaneous and oral administration, and the structure-activity relationships (SAR) were examined in detail. The results clearly indicated that compounds containing beta-amino acid without a side chain at the X position are preferable for expression of potent analgesic activity, and that the free carboxyl group is superior in its analgesic activity to that of the esterified or amidated carboxy group at the C-terminal. In addition, N-methylation of the amide bond at the 4th position contributed to improved analgesic activity. These results indicated that the strong and long-lasting analgesic effect of ADAMB is expressed by the synergistic effects of N(alpha)-amidination, the N-methylation of the amide bond at the 4th position and the carbon chain length (beta-Ala) of the residue at the 4th position, and that this is the most suitable structure.

UI MeSH Term Description Entries
D008297 Male Males
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D019943 Amino Acid Substitution The naturally occurring or experimentally induced replacement of one or more AMINO ACIDS in a protein with another. If a functionally equivalent amino acid is substituted, the protein may retain wild-type activity. Substitution may also diminish, enhance, or eliminate protein function. Experimentally induced substitution is often used to study enzyme activities and binding site properties. Amino Acid Substitutions,Substitution, Amino Acid,Substitutions, Amino Acid

Related Publications

Tadashi Ogawa, and Tetsuhisa Miyamae, and Toru Okayama, and Masaki Hagiwara, and Shinobu Sakurada, and Tadanori Morikawa
March 2001, European journal of pharmacology,
Tadashi Ogawa, and Tetsuhisa Miyamae, and Toru Okayama, and Masaki Hagiwara, and Shinobu Sakurada, and Tadanori Morikawa
December 1988, Chemical & pharmaceutical bulletin,
Tadashi Ogawa, and Tetsuhisa Miyamae, and Toru Okayama, and Masaki Hagiwara, and Shinobu Sakurada, and Tadanori Morikawa
September 1998, Methods and findings in experimental and clinical pharmacology,
Tadashi Ogawa, and Tetsuhisa Miyamae, and Toru Okayama, and Masaki Hagiwara, and Shinobu Sakurada, and Tadanori Morikawa
January 1985, Peptides,
Tadashi Ogawa, and Tetsuhisa Miyamae, and Toru Okayama, and Masaki Hagiwara, and Shinobu Sakurada, and Tadanori Morikawa
August 1993, European journal of pharmacology,
Tadashi Ogawa, and Tetsuhisa Miyamae, and Toru Okayama, and Masaki Hagiwara, and Shinobu Sakurada, and Tadanori Morikawa
November 2006, Peptides,
Tadashi Ogawa, and Tetsuhisa Miyamae, and Toru Okayama, and Masaki Hagiwara, and Shinobu Sakurada, and Tadanori Morikawa
June 1998, European journal of pharmacology,
Tadashi Ogawa, and Tetsuhisa Miyamae, and Toru Okayama, and Masaki Hagiwara, and Shinobu Sakurada, and Tadanori Morikawa
January 1986, British journal of pharmacology,
Tadashi Ogawa, and Tetsuhisa Miyamae, and Toru Okayama, and Masaki Hagiwara, and Shinobu Sakurada, and Tadanori Morikawa
February 1994, Biochemical Society transactions,
Tadashi Ogawa, and Tetsuhisa Miyamae, and Toru Okayama, and Masaki Hagiwara, and Shinobu Sakurada, and Tadanori Morikawa
February 2000, Peptides,
Copied contents to your clipboard!